Advertisement

Disease Burden and Disability-Adjusted Life Years Due to Schizophrenia and Psychotic Disorders

  • A. Theodoridou
  • W. Rössler
Reference work entry

Abstract:

 Schizophrenia usually starts in young adulthood. The cumulative lifetime risk for men and women is similar, although it is higher for men in the age group younger than 40 years. A common categorization of severe mental illness includes the schizophrenic and delusional disorders listed under e.g. categories F20–29 of the WHO International Classification of Diseases (ICD). Characteristic for the schizophrenic disorder is a distortion of thinking and perception and affects that are inappropriate or blunted.  Hallucinations, delusional perceptions and  delusion of controls are psychopathological phenomena that appear in schizophrenia. Diagnosis and treatment of schizophrenia are often delayed. Schizophrenia is one of the most burdensome and costly illnesses worldwide, because of onset, course and rate of disabilities. Family relationships suffer, if the burden of care is shifted to families. According to the Global Burden of Disease Study, schizophrenia causes a high degree of disability, which accounts for 1.1% of the total  DALYs (disability-adjusted life years) and 2.8% of YLDs (years lived with disability). Schizophrenia is listed as the eighth leading cause of DALYs worldwide in the age group 15–44 years, according to the WHO World Health Report: new understanding, new hope, 2001, Geneva. The risk of suicide is very high, 10–13% of people with schizophrenia commit suicide. Comorbid somatic conditions in people with schizophrenia can also lead to premature death. Optimizing the general health needs attention.

Keywords

Negative Symptom Severe Mental Illness Psychotic Disorder Positive Symptom Schizophrenia Spectrum Disorder 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

List of Abbreviations:

BPRS

brief psychiatric rating scale

DALY

disability-adjusted life year

DSM

diagnostic and statistical manual of mental disorders

GAF

global assessment of functioning

GBD

global burden of disease

ICD

international classification of diseases

MSQOL

 modular system for Quality of Life

PANSS

positive and negative syndrome scale

QOL

quality of life

QUALY

quality-adjusted life year

SF-36

Short-Form 36

WHO

world health organization

YLD

years lived with disability

YLL

years of lost life

References

  1. Addington D, Addington J, Patten S. (1998). Br J Psychiatry 172/Suppl. 33: 90–92.Google Scholar
  2. American Psychiatric Association. (2000). Diagnostic and Statistical Manual of Mental Disorders, Fourth Ed., Text Revision. American Psychiatric Association, Washington, DC.Google Scholar
  3. Andrews G, Sanderson K, Corry J, Issakidis C, Lapsley H. (2003). Br J Psychiatry. 183: 427–435.PubMedCrossRefGoogle Scholar
  4. Andrews G, Issakidis C, Sanderson K, Corry J, Lapsley H. (2004). Br J Psychiatry. 184: 526–533.PubMedCrossRefGoogle Scholar
  5. Bleuler E. (1911). Dementia praecox oder Gruppe der Schizophrenien. Deutike, Leipzig-Wien.Google Scholar
  6. Brown S. (1997). Br J Psychiatry. 171: 502–508.PubMedCrossRefGoogle Scholar
  7. Browne S, Clarke M, Gervin M, Waddington JL, Larkin C, O’Callaghan E. (2000). Br J Psychiatry. 176: 173–176.PubMedCrossRefGoogle Scholar
  8. Caldwell CB, Gottesman II. (1990). Schizophr Bull. 16(4): 571–589.PubMedGoogle Scholar
  9. Ehrenreich H, Sirén AL. (2002). In: Häfner H (ed.) Risk and Protective Factors in Schizophrenia. Steinkopff Verlag Darmstadt, pp. 257–262.Google Scholar
  10. Frohberg DG, Kane RL. (1989). J Clin Epidemiol. 42(4): 345–354.CrossRefGoogle Scholar
  11. Gaebel W, Jänner M, Frommann N, Pietzcker A, Köpke W, Linden M, Müller P, Müller-Spahn F. (2000). Compr Psychiatry. 41: 76–85.PubMedCrossRefGoogle Scholar
  12. Harwood RH, Sayer AA, Hirschfeld M. (2004). Bull World Health Organ. 82(4): 251–258.PubMedGoogle Scholar
  13. Häfner H, Maurer K, Löffler W, an der Heiden W, Könnecke R, Hambrecht M. (2002). In: Häfner H (ed.) Risk and Protective Factors in Schizophrenia. Steinkopff Verlag Darmstadt, pp. 207–228.Google Scholar
  14. Häfner H, Nowotny B, Löffler W, Heiden W, an der Maurer K. (1995). Eur Arch Psychiatry Clin Neurosci. 246(1): 17–28. 28.PubMedCrossRefGoogle Scholar
  15. Häfner H, Riecher-Rössler A, Hambrecht M, Maurer K, Meissner S, Schmidtke A, Faktenheuer B, Löffler W, an der W. Heiden (1992). Schizophr Res. 6: 209–223.PubMedCrossRefGoogle Scholar
  16. Heinisch M, Ludwig M, Bullinger M. (1991). Bullinger M, Ludwig M, von Steinbüchel N (ed.) Lebensqualität bei Kardiovaskulären Erkrankungen. Grundlagen, Messverfahren und Ergebnisse. Göttingen, Hogrefe, pp. 73–90.Google Scholar
  17. Ho BC, Nopoulos P, Flaum M, Arndt S, Andreasen NC. (1998). Am J Psychiatry. 155: 1196–1201.PubMedGoogle Scholar
  18. Hollinghurst S, Bevan G, Bowie C. (2000). Health Care Manag Sci. 3: 9–21.PubMedCrossRefGoogle Scholar
  19. Jablensky A, Sartorius N, Ernberg G, Anker M, Korten A, Cooper JE, Day R, Bertelsen A. (1992). Schizophrenia: Manifestations, Incidence and Course in Different Cultures. Cambridge University Press.Google Scholar
  20. Jaspers K. (1913/1963). General Psychopathology. Manchester University Press (orig.: Allgemeine Psychopathologie, Springer Verlag, Berlin).Google Scholar
  21. Jungbauer J, Wittmund B, Dietrich S, Angermeyer MC. (2004). Schizophr Bull. 30(3): 665–675.PubMedGoogle Scholar
  22. Kaplan & Sadock’s Comprehensive Textbook of Psychiatry, 8th ed., Lippincott Williams & Wilkins, pp. 1096–1232.Google Scholar
  23. Knapp M, Chisholm D, Leese M, Amaddeo F, Tansella M, Schene A, Thornicroft G, Vasquez-Barquero JL, Knudson HC, Becker T. (2002). Acta Psychiatr Scand. 105(1): 42–54.PubMedCrossRefGoogle Scholar
  24. Kelly J, Murray RM, van Os J. (2001). The outcome of psychotic illness. In: Lieberman J, Murray RM (ed.). The Comprehensive Care of Schizophrenia. Dunitz, London, pp. 1531–1539.Google Scholar
  25. Kraepelin E. (1896). Psichiatrie, 5th ed. Barth, Leipzig.Google Scholar
  26. Lauber C, Eichenberger A, Luginbuhl P, Keller C, Rössler W. (2003). Eur Psychiatry. 18(6): 285–289.PubMedCrossRefGoogle Scholar
  27. McGlashan TH, Johannessen JO. (1996). Schizophr Bull. 22(2): 201–222.PubMedGoogle Scholar
  28. McGrath J, Sukanta S, Welham J, El Saadi O, MacCauley C, Chant D. (2004). BMC Med. 2: 13.PubMedCrossRefGoogle Scholar
  29. Magliano L, Fiorillo A, De Rosa C, Malangone C, Maj M. (2005). Soc Sci Med. 61(2): 313–322.PubMedCrossRefGoogle Scholar
  30. Magliano L, Marasco C, Fiorillo A, Malangone C, Guameri M, Maj M. (2002). Acta Psychiatr Scand. 106: 291–298.PubMedCrossRefGoogle Scholar
  31. Miller TJ, McGlashan TH, Woods SW, Stein K, Driesen N, Corcoran CM, Hoffman R, Davidson L. (1999). Psychiatr Q. 70: 273–287.PubMedCrossRefGoogle Scholar
  32. Murray CJL, Lopez AD. (1996). The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability from Diseases, Injuries and Risk Factors in 1990 and Projected to 2020. Global Burden of Disease and Injury Series, Vol. 1.Harvard School of Public Mental Health, Cambridge, MA.Google Scholar
  33. Murray CJL, Lopez AD. (1997). Lancet 349(9064): 1498–1504.PubMedCrossRefGoogle Scholar
  34. Patel V, Flisher AJ, Hetrick S, McGorry PM. (2007). Lancet. 369: 1302–1313.PubMedCrossRefGoogle Scholar
  35. Pukrop R, Schlaak V, Möller-Leimkühler AM, Albus M, Czernik A, Klosterkötter J, Möller HJ. (2003). Psychiatry Res. 119: 63–79.PubMedCrossRefGoogle Scholar
  36. Radomsky ED, Haas GL, Mann JJ, Sweeny JA. (1999). Am J Psychiatry. 156(10): 1590–1595.PubMedGoogle Scholar
  37. Rössler W, Salize HJ, Cucchiaro G, Reinhard I, Kernig C. (1999). Acta Psychiatr Scand. 100: 142–148.PubMedCrossRefGoogle Scholar
  38. Rössler W, Salize HJ, Knapp M. (1998). Fortschr Neurol Psychiattr. 66(11): 496–504.CrossRefGoogle Scholar
  39. Rössler W, Salize HJ, van Os J, Riecher-Rössler A. (2005). Eur Neuropsychopharmacol. 15: 399–409.PubMedCrossRefGoogle Scholar
  40. Saha S, Chant D, McGrath J. (2007). Arch Gen Psychitry. 64(10): 1123–1131.CrossRefGoogle Scholar
  41. Salokangas RK, Honkonen T, Stengard E, Koivisto AM. (2006). Psychiatr Serv. 57(3): 373–381.PubMedCrossRefGoogle Scholar
  42. Schulze B, Rössler W. (2005). Curr Opin Psychiatry. 18: 684–691.PubMedCrossRefGoogle Scholar
  43. Sim K, Mahendran R, Siris SG, Heckers S, Chong SA. (2004). Psychiatry Res. 129: 141–147.PubMedCrossRefGoogle Scholar
  44. Statistisches Bundesamt. (2004). Krankheitskosten 2002. Wiesbaden.Google Scholar
  45. Stuart H, Arboleda-Florez J. (2001). Can J Psychiatry. 46(3): 245–252.PubMedGoogle Scholar
  46. The ICD-10 Classification of Mental and Behavioural Disorders. (1992). World Health Organization, Geneva.Google Scholar
  47. The WHO World Health Report: New Understanding, New Hope. Geneva, 2001.Google Scholar
  48. Thornicroft G, Tansella M, Becker T, Knapp M, Leese M, Schene A. (2004). Schizophr Res. 69(2–3): 125–132.PubMedCrossRefGoogle Scholar
  49. Üstün TB, Rehm J, Chatterji S, Saxena S, Trotter R, Room R, Bickenbach J. (1999). Lancet. 354(9173): 111–115.PubMedCrossRefGoogle Scholar
  50. Van Os J, Marcelis M. (1998). Schizophr Res. 32: 127–135.PubMedCrossRefGoogle Scholar
  51. Wilson IB, Cleary PD. (1995). JAMA. 273: 59–65.PubMedCrossRefGoogle Scholar
  52. Wittchen HU, Jacobi F. (2005). Eur Neuropsychopharmacol. 15: 357–376.PubMedCrossRefGoogle Scholar
  53. Yung AR, McGorry PD. (1996). Schizophr Bull. 22: 353–370.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media LLC 2010

Authors and Affiliations

  • A. Theodoridou
  • W. Rössler

There are no affiliations available

Personalised recommendations